1 month ago

Sun Pharma Q1 FY27 Net Profit Rises 27% to ₹2,894.8 Crore

Sun Pharma Q1 FY27 Net Profit Rises 27% to ₹2,894.8 Crore
Sun Pharma Q1 Net Profit Up 27%, Revenue Rises 10.1% To ₹15,183.55 Crore · freepressjournal.in

Sun Pharma is a big drug company in India.

In the first part of its 2027 financial year, it made more money than last year, earning about ₹2,895 crore after taxes.

Its total sales went up to about ₹15,184 crore.

The company spent about ₹11,721 crore on everything, including paying its workers.

It had some extra costs from buying another company and new labor rules, but it also got a tax credit that helped.

The profit per share was ₹12.1, higher than the ₹9.5 it earned last year, and its earnings before interest, taxes, depreciation, and amortization (EBITDA) margin was 28.9%.

Key facts

Net profit after tax
₹2,894.8 crore
Consolidated revenue
₹15,183.55 crore
Total expenses
₹11,720.60 crore
Exceptional items
₹204.09 crore
Earnings per share
₹12.1
EBITDA margin
28.9%

Sources

Related news